{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-14400", "open" : "1247491846", "close" : "1247515246", "flags" : {}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}

Send us feedback. Tell us what you think about the new Article Page. Send us feedback

marketwire

Active Biotech AB Interim Report January-September 2008

  • Press Release
  • Source: Active Biotech
  • On Friday November 14, 2008, 2:30 am EST

LUND, SWEDEN--(MARKET WIRE)--Nov 14, 2008 -- 

 
- Laquinimod -- positive data presented from extension study

- 57-57 -- Clinical Phase II/III trial to commence in 2009

- RhuDex® -- Additional preclinical tests under way

- ANYARA -- Phase III study proceeding as planned

- TASQ -- Phase II study proceeding as planned

- Net sales SEK 8.8 M (8.7)

- Operating loss SEK 167.0 M (loss: 147.8 )

- Loss after tax SEK 162.0 M (loss: 152.0)

- Loss per share for the period amounted to SEK 3.30 (loss: 3.30)


For further information, please contact:
Tomas Leanderson
President and CEO
Tel: +46 (0)46-19 20 95

Göran Forsberg
VP Investor Relations & Business Development
Tel: +46 (0)46-19 11 54

Hans Kolam
CFO
Tel: +46 (0)46-19 20 44

Active Biotech AB
(Corp. Reg. No. 556223-9227)
PO Box 724, SE-220 07 Lund
Tel: +46 (0)46-19 20 00
Fax: +46 (0)46-19 11 00

This report is also available at www.activebiotech.com


This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.



Copyright © Hugin AS 2008. All rights reserved.

Contact:

Top Stories

Sponsored Links

Copyright © 2009 Marketwire. All rights reserved. All the news releases provided by Marketwire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.